Advance to Seller – Related Party
|12 Months Ended|
Dec. 31, 2020
|Advance to Seller Related Party [Abstract]|
|ADVANCE TO SELLER – RELATED PARTY||
4 — ADVANCE TO SELLER – RELATED PARTY
In connection with entry into a December 7, 2020 equity purchase agreement with Purnovate, Inc., an early stage drug development company with a focus on purine chemistry and successor to Purnovate, LLC (henceforth "Purnovate"), the Company loaned Purnovate $350,000 to continue its research and development efforts during the due diligence period specified in the agreement, and issued a 3.5% promissory note due December 7, 2021. In the event the acquisition were terminated, the bridge note would become convertible, at the option of the Company, into equity of Purnovate at a conversion price of $1.50. The proceeds of the Bridge Note were to be used by Purnovate to fund ongoing research and development, working capital, and other general corporate purposes. See Notes 6 and 10.